Gwalior, Mar 20: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company in India to have achieved 100% NABL accreditation across all its laboratories, has announced the launch of its first diagnostic laboratory in Gwalior, Madhya Pradesh, in association with Excellence Diagnostics. The facility was inaugurated by Piyush Singh, Vice President, Thyrocare. Thyrocare now operates three laboratories in Madhya Pradesh, including its existing presence in Bhopal and Indore, further strengthening access to diagnostic services across the state.
The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling accurate and timely diagnostic results. It is designed to cater to both routine and specialised testing requirements, supporting preventive and ongoing healthcare needs.
This expansion is aligned with Thyrocare’s continued focus on strengthening its network and addressing the growing demand for reliable diagnostic services in emerging markets. The Gwalior facility further expands the company’s presence in central India.
Commenting on the launch of the new lab in Gwalior, Rahul Guha, MD and CEO, Thyrocare, said,
“At Thyrocare, our focus is on making high-quality and reliable diagnostic services accessible to every Indian household. The launch of our new facility reflects our continued efforts to expand our presence while addressing diagnostic gaps through a technology-led and patient-focused approach.”
Rajdeep Panwar, Chief Commercial Officer, Thyrocare, shared,
“Our focus in markets like Gwalior is on improving last-mile access and ensuring that both patients and healthcare partners have access to consistent and timely diagnostic services. This facility allows us to strengthen our reach in the region while maintaining the quality and turnaround standards that Thyrocare is known for.”
With this launch, Thyrocare continues to expand its presence in Madhya Pradesh, with a focus on making diagnostic services more accessible across cities beyond metro markets. The company remains committed to strengthening its network and bringing reliable healthcare services closer to patients.
